Med2Date — Clinical Guidelines
Home Infectious Disease Genital itch

Genital itch

Last updated 22 Mar 2026 · Male Infection

Genital Itch - Male Infectious Causes

Introduction & Australian Epidemiology

Genital pruritus in males represents a common presenting complaint in Australian primary care and sexual health clinics. Infectious causes account for approximately 60-70% of cases, with fungal infections (particularly Candida albicans) being the most prevalent, followed by sexually transmitted infections (STIs) and bacterial causes.

Key epidemiological considerations for Australia include:

  • Higher rates of Trichomonas vaginalis and other STIs in remote Aboriginal and Torres Strait Islander communities
  • Increased incidence of candidal balanitis in tropical/subtropical regions (Queensland, Northern Territory, Western Australia)
  • Rising rates of antimicrobial-resistant gonorrhoea, particularly in urban centres
  • Seasonal variation in fungal infections, peaking during humid summer months
ℹ️
Clinical Context: While non-infectious causes (eczema, psoriasis, contact dermatitis) are important differentials, this guideline focuses specifically on infectious aetiologies requiring antimicrobial therapy.

Pathophysiology & Microbiology

Fungal Infections

Candidal Balanitis/Balanoposthitis: Candida albicans (85-90%) and non-albicans species (C. glabrata, C. tropicalis) cause inflammatory response in glans penis and prepuce. Risk factors include diabetes, immunosuppression, poor hygiene, and tight foreskin.

Dermatophyte Infections: Trichophyton rubrum, T. mentagrophytes, and Epidermophyton floccosum cause tinea cruris extending to genital area. Warm, moist conditions promote growth.

Sexually Transmitted Infections

Bacterial STIs:

  • Chlamydia trachomatis - causes urethritis, potential penile irritation
  • Neisseria gonorrhoeae - urethritis with secondary genital irritation
  • Trichomonas vaginalis - parasitic infection causing urethritis and balanitis

Viral STIs:

  • Herpes simplex virus (HSV-1, HSV-2) - vesicular lesions with intense pruritus
  • Human papillomavirus (HPV) - genital warts with associated irritation

Clinical Presentation & Diagnostic Criteria

Mild
Localised Pruritus
Intermittent itching, minimal erythema, no systemic symptoms
Outpatient management
Moderate
Inflammatory Response
Persistent itching, visible lesions, local swelling, discharge
GP or sexual health clinic
Severe
Complicated Infection
Severe pain, ulceration, systemic symptoms, recurrent episodes
Specialist referral indicated

Clinical Features by Aetiology

Candidal Balanitis

  • Intense pruritus and burning
  • Erythematous, oedematous glans
  • White, cottage cheese-like discharge
  • Possible fissuring of foreskin
  • Sweet, yeasty odour

Trichomonas Infection

  • Burning, itching sensation
  • Frothy, yellow-green discharge
  • Dysuria
  • Erythematous urethral opening
  • Offensive fishy odour
⚠️
Red Flags: Painful ulceration, lymphadenopathy, systemic symptoms, or failure to respond to first-line therapy warrant immediate specialist assessment and consideration of HSV, syphilis, or other complex infections.

Investigations

  • Essential
    Clinical History & Examination
    Sexual history, recent antibiotics, diabetes screening, visual inspection of genitalia
  • Available
    Swab for Microscopy & Culture
    Glans/urethral swab for fungal culture, bacterial culture if indicated. Available at all pathology centres.
  • Available
    STI Screening Panel
    Chlamydia, gonorrhoea (NAAT), syphilis serology, HIV. First-void urine or urethral swab. Medicare item 69316-69321.
  • Available
    Trichomonas PCR
    High sensitivity test for T. vaginalis. Available at major pathology centres, Medicare item 69491.
  • Referral
    HSV PCR
    If vesicular lesions present. Swab from vesicle base. Available at reference laboratories.
  • Available
    KOH Preparation
    Point-of-care test for candida. 10% KOH preparation shows budding yeasts and hyphae.
  • Essential
    Blood Glucose Level
    Fasting glucose or HbA1c if recurrent fungal infections. Medicare item 66695.

Risk Stratification & Severity Scoring ★ NEW

Low Risk
Single episode, no comorbidities, localised symptoms
Outpatient management
Empirical therapy appropriate
Moderate Risk
Diabetes, immunosuppression, recurrent episodes
Enhanced monitoring
Culture-directed therapy preferred
High Risk
Severe immunocompromise, treatment failure, complications
Specialist referral
Extended therapy, resistance testing

Empirical Antimicrobial Therapy

First-Line Therapy

🍄
Clotrimazole
Canesten® · Topical Antifungal · First-line
Adult Dose 1% cream, apply twice daily
Paediatric Same as adult dose if >2 years
Route Topical application
Frequency Twice daily
Duration 7-14 days
Renal Adj. None required
Hepatic Adj. None required
PBS Status ✓ PBS General Benefit
💊
Fluconazole
Diflucan® · Oral Antifungal · Severe cases
Adult Dose 150 mg single dose
Paediatric 3 mg/kg single dose (max 150 mg)
Route Oral
Frequency Single dose, may repeat in 3 days
Duration 1-2 doses
Renal Adj. 50% dose if CrCl <50 mL/min